MediumEndocrinologyType 2 diabetes mellitus with cardiovascular diseaseau-racpau-amc
A 56-year-old man with long-standing type 2 diabetes (HbA1c 8.4%) and obesity (BMI 34 kg/m²) is on maximum tolerated metformin. He has established atherosclerotic cardiovascular disease but preserved renal function. According to current Australian algorithms, what is the MOST appropriate next glucose-lowering agent?